Market
CareDx sharpens precision medicine focus with $260m Naveris acquisition
CareDx announced a $260 million acquisition of Naveris, a precision medicine company, as part of a strategic shift following the recent divestment of its lab products business. The move reflects CareDx's decision to refocus on precision medicine after its lab segment reported flat Q1 revenue.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network